Chemotherapy News and Research

Latest Chemotherapy News and Research

Combination treatment can provide long remissions for young patients with chronic lymphocytic leukemia

Young patients with chronic lymphocytic leukemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefinitely to keep the cancer in remission.

13 Dec 2021

Study offers new hope for large B-cell lymphoma patients

Of the 18,000 people diagnosed with large B-cell lymphoma each year, only half will be successfully treated with chemotherapy. The 9,000 remaining patients typically have poor outcomes, with only 25% responding to additional, higher-intensity chemotherapy, followed by a stem cell transplant.

13 Dec 2021

Drug combination without chemotherapy can be effective in treating older patients with Ph+ ALL

The combination of dasatinib, blinatumomab, and prednisone can be effective in treating older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who are not good candidates for intensive chemotherapy treatment.

13 Dec 2021

NCCN publishes new guidelines to help cervical cancer patients become more informed about care

The National Comprehensive Cancer Network has published new NCCN Guidelines for Patients: Cervical Cancer to help people with cervical cancer become more informed, suggest what conversations to have with their doctor, and be active decision makers in their treatment.

13 Dec 2021

Novel immunotherapy shows promise for children, young adults with recurrent AML

An immunotherapy harnessing the immune system's "natural killer" cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return.

12 Dec 2021

Statistical models predict outcomes for patients receiving non-intensive AML therapy

An international team has developed statistical models to predict the risk of early death in patients being treated with non-intensive therapies for acute myeloid leukemia (AML).

12 Dec 2021

Clinical studies show enhanced responses for lymphoma patients treated with axi-cel CAR T cell therapy

Three clinical studies led by researchers at The University of Texas MD Anderson Cancer Center demonstrated enhanced responses for patients with high-risk lymphoma treated with axicabtagene ciloleucel (axi-cel) chimeric antigen receptor (CAR) T cell therapy.

12 Dec 2021

Infantile cataracts are more common and problematic than thought

Three days after Canyon Brown was born, the attending pediatrician discovered a problem.

8 Dec 2021

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination.

7 Dec 2021

Scientists find new way to reverse aggressive breast cancer into a less dangerous kind

Scientists at KAIST believe they may have found a way to reverse an aggressive, treatment-resistant type of breast cancer into a less dangerous kind that responds well to treatment.

7 Dec 2021

Stand Up To Cancer - An Interview with Chris Draft

In this inspiring interview, we speak to former NFL player Chris Draft about lung cancer, and how he has partnered with SU2C to help raise awareness surrounding it.

7 Dec 2021

Study finds mRNA-based COVID-19 vaccines are effective in cancer patients

The mRNA-based COVID-19 vaccines are effective at preventing infection in most cancer patients, according to a nationwide study of veterans diagnosed with cancer in the past decade.

6 Dec 2021

Novel monoclonal antibody could help revolutionize treatment of children with high-risk neuroblastoma

Survival rates increased about 20% for children with high-risk neuroblastoma enrolled in a St. Jude Children’s Research Hospital clinical trial that included a novel monoclonal antibody produced onsite. The findings appeared today in the Journal of Clinical Oncology.

6 Dec 2021

New protein variant underlies the ability of gastric cancers to resist chemotherapy

A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team at Weill Cornell Medicine. The results suggest a treatment strategy that could improve the prognoses of many patients with cancer.

6 Dec 2021

Mutations in a crucial gene responsible for chemotherapy failure in some blood cancer patients

Mutations in a crucial gene are the key reason that chemotherapy fails in some patients with blood cancer, a study by Nanyang Technological University, Singapore (NTU Singapore) and Singapore General Hospital (SGH) has found.

6 Dec 2021

Probiotics significantly improve the symptoms of pregnancy-related problems

In a first-of-its-kind study, researchers at the UC Davis School of Medicine found that probiotics significantly improve the symptoms of pregnancy-related nausea, vomiting and constipation. The findings were published in the journal Nutrients.

6 Dec 2021

COVID-19 vaccines shown to reduce SARS-CoV-2 infection rate in cancer patients

A study recently published in the journal JAMA Oncology has stated that coronavirus disease 2019 (COVID-19) vaccines are more than 55% effective in reducing the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in cancer patients.

5 Dec 2021

Chemotherapy News and Research

Latest Chemotherapy News and Research

Combination treatment can provide long remissions for young patients with chronic lymphocytic leukemia

Study offers new hope for large B-cell lymphoma patients

Drug combination without chemotherapy can be effective in treating older patients with Ph+ ALL

NCCN publishes new guidelines to help cervical cancer patients become more informed about care

Novel immunotherapy shows promise for children, young adults with recurrent AML

Statistical models predict outcomes for patients receiving non-intensive AML therapy

Clinical studies show enhanced responses for lymphoma patients treated with axi-cel CAR T cell therapy

Infantile cataracts are more common and problematic than thought

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Scientists find new way to reverse aggressive breast cancer into a less dangerous kind

Stand Up To Cancer - An Interview with Chris Draft

Study finds mRNA-based COVID-19 vaccines are effective in cancer patients

Novel monoclonal antibody could help revolutionize treatment of children with high-risk neuroblastoma

New protein variant underlies the ability of gastric cancers to resist chemotherapy

Mutations in a crucial gene responsible for chemotherapy failure in some blood cancer patients

Probiotics significantly improve the symptoms of pregnancy-related problems

COVID-19 vaccines shown to reduce SARS-CoV-2 infection rate in cancer patients

AI-driven medical imaging may help fight against rectal cancer

New genetic technology for gene expression analysis of cancer cells

Modulating the composition of bacterial populations in the colon could enhance anti-tumor immunity

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in